Pyruvaldehyde
(AIJULSRZWUXGPQ-UHFFFAOYSA-N)
Structure
- SMILES
- O=CC(=O)C
- Type(s)
- Experimental
- Molecular Formula:
- C3H4O2
- Molecular Weight:
- 72.063
- Log P:
- -0.2257
- Hydrogen Bond Acceptor:
- 2
- Hydrogen Bond Donor:
- 0
- TPSA:
- 34.14
- CAS Number(s):
- 78-98-8; 51252-84-7
Synonym(s)
1.
Pyruvaldehyde
2.
Acetylformaldehyde
3.
Methylglyoxal
4.
Oxopropanal
5.
Pyruvic Aldehyde
6.
Aldehyde, Pyruvic
External Link(s)
| MeSH | D011765 |
| PubChem Compound | 880 |
| ChEBI | 17158 |
| CHEMBL | CHEMBL170721 |
| DrugBank | DB03587 |
| IUPHAR/BPS Guide to PHARMACOLOGY | 6303 |
| KEGG | cpd:C00546 |
| Therapeutic Target Database | D07QPX D0G4CI |
| ZINC | 1532681 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Cardiovascular Diseases | 23954466 | CTD | |
| 2 | Chemical and Drug Induced Liver Injury | 20211157 | CTD | |
| 3 | Diabetes Mellitus | CTD | ||
| 4 | Diabetic Cardiomyopathies | 20621070 | CTD | |
| 5 | Diabetic Retinopathy | 20621070 | CTD | |
| 6 | Hyperglycemia | 11719831 23954466 | CTD | |
| 7 | Hypersensitivity | 17347135 | CTD | |
| 8 | Inflammation | 17347135 22101032 23954466 | CTD | |
| 9 | Insulin Resistance | 22917016 23954466 | CTD | |
| 10 | Necrosis | 11331073 | CTD | |
| 11 | Osteoporosis | 31103701 | CTD | |
| 12 | Peritoneal Fibrosis | 22101032 | CTD | |
| 13 | Precancerous Conditions | 7821871 | CTD |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.